FR2293931B1 - - Google Patents

Info

Publication number
FR2293931B1
FR2293931B1 FR7440233A FR7440233A FR2293931B1 FR 2293931 B1 FR2293931 B1 FR 2293931B1 FR 7440233 A FR7440233 A FR 7440233A FR 7440233 A FR7440233 A FR 7440233A FR 2293931 B1 FR2293931 B1 FR 2293931B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7440233A
Other languages
French (fr)
Other versions
FR2293931A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7440233A priority Critical patent/FR2293931A1/en
Priority to IL48508A priority patent/IL48508A/en
Priority to ES442910A priority patent/ES442910A1/en
Priority to DE2552869A priority patent/DE2552869C2/en
Priority to ZA7444A priority patent/ZA757444B/en
Priority to SE7513391A priority patent/SE408422B/en
Priority to US05/636,098 priority patent/US3993764A/en
Priority to CA240,857A priority patent/CA1089766A/en
Priority to GB49210/75A priority patent/GB1529329A/en
Priority to GB2344/78A priority patent/GB1529330A/en
Priority to AU87173/75A priority patent/AU498955B2/en
Priority to MX004196U priority patent/MX3046E/en
Priority to NL7514255A priority patent/NL7514255A/en
Priority to BE162540A priority patent/BE836391A/en
Priority to CH1594675A priority patent/CH605915A5/xx
Priority to LU73947A priority patent/LU73947A1/xx
Priority to DK553175AA priority patent/DK139580B/en
Priority to JP50145182A priority patent/JPS5186475A/ja
Priority to IE2675/75A priority patent/IE42618B1/en
Publication of FR2293931A1 publication Critical patent/FR2293931A1/en
Application granted granted Critical
Publication of FR2293931B1 publication Critical patent/FR2293931B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
FR7440233A 1974-12-09 1974-12-09 Antidepressant, antiemetic and anti Parkinson 3-(4-piperidyl) indoles - e.g. 5-methoxy-3-(4-piperidyl)indole Granted FR2293931A1 (en)

Priority Applications (19)

Application Number Priority Date Filing Date Title
FR7440233A FR2293931A1 (en) 1974-12-09 1974-12-09 Antidepressant, antiemetic and anti Parkinson 3-(4-piperidyl) indoles - e.g. 5-methoxy-3-(4-piperidyl)indole
IL48508A IL48508A (en) 1974-12-09 1975-11-20 Pharmaceutical compositions comprising piperidylindole derivatives
ES442910A ES442910A1 (en) 1974-12-09 1975-11-24 Treatment of depressive states and Parkinson{3 s disease
DE2552869A DE2552869C2 (en) 1974-12-09 1975-11-25 Pharmaceutical compositions containing piperidylindole derivatives
ZA7444A ZA757444B (en) 1974-12-09 1975-11-26 A pharmaceutical composition containing at least one piperidyl-indole
SE7513391A SE408422B (en) 1974-12-09 1975-11-27 ANALOGICAL PROCEDURE FOR PREPARING SALTS OF PIPERIDYL CONTENT DERIVATIVES
US05/636,098 US3993764A (en) 1974-12-09 1975-11-28 Treatment of depressive states and Parkinson's disease
GB49210/75A GB1529329A (en) 1974-12-09 1975-12-01 Pharmaceutical compositions containing piperidylindole derivatives
GB2344/78A GB1529330A (en) 1974-12-09 1975-12-01 Acid addition salts of 3-(4'-piperidyl)-indole derivative
CA240,857A CA1089766A (en) 1974-12-09 1975-12-01 Pharmaceutic applications of piperidyl-indole derivatives
AU87173/75A AU498955B2 (en) 1974-12-09 1975-12-02 3-(4'-piperidyl) indoles
MX004196U MX3046E (en) 1974-12-09 1975-12-02 PROCEDURE FOR THE PREPARATION OF ADDITION SALTS OF PIPERIDIL - INDOL DERIVATIVES
NL7514255A NL7514255A (en) 1974-12-09 1975-12-08 PROCESS FOR THE PREPARATION OF PIPERIDYLINDOLS AND PHARMACEUTICAL PREPARATIONS CONTAINING THEY.
BE162540A BE836391A (en) 1974-12-09 1975-12-08 NEW PHARMACEUTICAL COMPOSITIONS CONTAINING A DERIVATIVE OF PIPERIDYL INDOLE OR ONE OF ITS SALTS
CH1594675A CH605915A5 (en) 1974-12-09 1975-12-08
LU73947A LU73947A1 (en) 1974-12-09 1975-12-08
DK553175AA DK139580B (en) 1974-12-09 1975-12-08 Analogous process for the preparation of addition salts of piperidylindole derivatives.
JP50145182A JPS5186475A (en) 1974-12-09 1975-12-08
IE2675/75A IE42618B1 (en) 1974-12-09 1975-12-09 New pharmaceutical compositions containing piperidyl-indole derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7440233A FR2293931A1 (en) 1974-12-09 1974-12-09 Antidepressant, antiemetic and anti Parkinson 3-(4-piperidyl) indoles - e.g. 5-methoxy-3-(4-piperidyl)indole

Publications (2)

Publication Number Publication Date
FR2293931A1 FR2293931A1 (en) 1976-07-09
FR2293931B1 true FR2293931B1 (en) 1978-07-21

Family

ID=9145754

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7440233A Granted FR2293931A1 (en) 1974-12-09 1974-12-09 Antidepressant, antiemetic and anti Parkinson 3-(4-piperidyl) indoles - e.g. 5-methoxy-3-(4-piperidyl)indole

Country Status (3)

Country Link
BE (1) BE836391A (en)
FR (1) FR2293931A1 (en)
ZA (1) ZA757444B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2426465B1 (en) * 1978-01-16 1983-04-29 Roussel Uclaf

Also Published As

Publication number Publication date
ZA757444B (en) 1977-01-26
FR2293931A1 (en) 1976-07-09
BE836391A (en) 1976-06-08

Similar Documents

Publication Publication Date Title
DK139580C (en)
FR2262520B1 (en)
JPS50142827A (en)
FR2293931B1 (en)
JPS50138466U (en)
JPS50116478A (en)
JPS50140157A (en)
BG23080A1 (en)
CH577330A5 (en)
CH577283A5 (en)
CH577049A5 (en)
CH576820A5 (en)
CH577803A5 (en)
CH577948A5 (en)
CH576624A5 (en)
CH576401A5 (en)
CH576025A5 (en)
CH575720A5 (en)
CH575490A5 (en)
CH578278A5 (en)
CH578369A5 (en)
CH575298A5 (en)
CH575082A5 (en)
CH573592A5 (en)
CH577664A5 (en)

Legal Events

Date Code Title Description
ST Notification of lapse